Literature DB >> 6341027

Metabolism and pharmacokinetics of theophylline in human neonates, children, and adults.

T J Haley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341027     DOI: 10.3109/03602538308991392

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  9 in total

1.  Lack of effect of highly purified subunit influenza vaccination on theophylline metabolism.

Authors:  P A Winstanley; J Tjia; D J Back; D Hobson; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

2.  New method for bioavailability assessment of slow-release preparations of theophylline.

Authors:  Y Kasuya; T Ohno; N Kubota; H Takahashi; H Hirayama
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

Review 3.  The Impact of CYP1A2 and CYP2E1 Genes Polymorphism on Theophylline Response.

Authors:  Em Sutrisna
Journal:  J Clin Diagn Res       Date:  2016-11-01

Review 4.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

Review 5.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 6.  Anti-allergy and anti-asthma drugs. Disposition in infancy and childhood.

Authors:  G D Sweeney; S M MacLeod
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

7.  The influence of ofloxacin and enoxacin on the metabolic pathways of theophylline in healthy volunteers. A pilot study.

Authors:  W J Wijnands; T J Janssen; P J Guelen; T B Vree; T M De Witte
Journal:  Pharm Weekbl Sci       Date:  1988-12-09

Review 8.  Clinical pharmacokinetics of vasodilators. Part II.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

9.  Bioluminescent Antibodies for Point-of-Care Diagnostics.

Authors:  Lin Xue; Qiuliyang Yu; Rudolf Griss; Alberto Schena; Kai Johnsson
Journal:  Angew Chem Int Ed Engl       Date:  2017-05-16       Impact factor: 15.336

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.